Thrombopoietin Receptor Agonist Market Overview

Ajouter une nouvelle offre d'emploi Health

2026-07-03 09:49:00 -

The Thrombopoietin Receptor Agonist Market was valued at USD 2.4 billion in 2024 and is projected to reach USD 6.8 billion by 2035, growing at a CAGR of 9.9%. These agents stimulate platelet production by activating the thrombopoietin receptor, offering effective treatment for thrombocytopenia-related disorders. The market serves three primary therapeutic applications: immune thrombocytopenic...

0 Commentaires 0 Parts 80 Vue 0 Aperçu